AMPCs_EN_202201_V3

§ Autologous Stem Cell Technology (ASCT) is an Australian stem cell company established in July 2011 § First in patenting a method of producing multi-lineage potential stem cells without genetic manipulation § Autologous Multilineage Potential Cells (AMPCs) can differentiate (transform) into any cell type of the body § In 2011, the Australian Therapeutic Good Administration (TGA) deemed AMPCs as goods exempt from regulation under the Therapeutics Goods Order No. 1 of 2011 § AMPCs are used in over 400 treatments for various degenerative diseases § AMPC are the only stem cell product in Australia to receive insurance protection. Lloyd's of London provides insurance coverage and no claims have been made since 2011. Company Introduction